Personal communication. Roche Laboratories, December 1991
3.
AHFS Drug Information: Midazolam. Am Soc Hosp Pharm, 1992, pp 1345-1349
4.
Dundee J.; Halliday N., Harper K., et al: Midazolam: A review of its pharmacological properties and therapeutic effectDrugs28:519-543, 1984
5.
Crevoisier PC , Eckert M, Heizmann, et al: Relation between clinical effect and the pharmacokinetics of midazolam following IM and IV administration. Arzneim ForshDrug Res31:2211-2215, 1981
6.
Gemperle M., Knapp W.: Midazolam and anaesthesia. Br J Clin Pharmacol16:1875-1905, 1983
7.
Kretz F., Dorrah T., Heinemeier G., et al: Serum levels following IV, IM, or rectal applications in young children. Naunyn Schmiedeberg's Arch Pharmacol334:R12, 1986 (suppl)
8.
Blumer J., Weissman B., Horwitz S., et al: Midazolam sedation for CT in children: Pharmacokinetics and pharma-. codynamics, part 2. Acta Pharmacol Toxicol59:75, 1986
9.
Rosen D., Rosen K.: A palatable gelatin vehicle for midazolam and ketamine. Anesthesiology75:914-915, 1991
10.
Payne K., Mattheyse F., Uebenberg D., et al: The pharmacokinetics of midazolam in paediatric patients. Eur J Clin Pharmacol37:267-272, 1989
11.
Steedman S., Koonce J., Brahen N., et al: Midazolam stability in a flavored dye-free oral solution. ASHP Midyear Meeting, New Orleans, December 1991 (abstr)
12.
Sievers T., Yee JD, Foley M., et al: Midazolam for conscious sedation during pediatric oncology procedures: Safety and recovery parameters. Pediatrics88:1172-1178, 1991
13.
Jjjajni K. , Sujit P.: Use of midazolam hydrochloride in anesthesia . Clin Pharmacol6:553-547, 1987
14.
RevesJG, Fragen RJ, et al: Midazolam: Pharmacology and users. Anesthesiology62:310-324, 1985
15.
Mazicon package insertRoche Laboratories , Nutley, NJ, December 1991
